Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia.

Molina JL, Calvó M, Padilla E, Balda M, Alemán GG, Florenzano NV, Guerrero G, Kamis D, Rangeon BM, Bourdieu M, Strejilevich SA, Conesa HA, Escobar JI, Zwir I, Cloninger CR, de Erausquin GA.

NPJ Schizophr. 2017 Jan 11;3:16036. doi: 10.1038/npjschz.2016.36.

2.
3.
4.

The Standard for Clinicians' Interview in Psychiatry (SCIP): A Clinician-administered Tool with Categorical, Dimensional, and Numeric Output-Conceptual Development, Design, and Description of the SCIP.

Aboraya A, Nasrallah H, Muvvala S, El-Missiry A, Mansour H, Hill C, Elswick D, Price EC.

Innov Clin Neurosci. 2016 Jun 1;13(5-6):31-77. Review.

5.

The Very Low-Dose Dexamethasone Suppression Test in the General Population: A Cross-Sectional Study.

Direk N, Dekker MJ, Luik AI, Kirschbaum C, de Rijke YB, Hofman A, Hoogendijk WJ, Tiemeier H.

PLoS One. 2016 Oct 13;11(10):e0164348. doi: 10.1371/journal.pone.0164348.

6.

Volumetric, relaxometric and diffusometric correlates of psychotic experiences in a non-clinical sample of young adults.

Drakesmith M, Dutt A, Fonville L, Zammit S, Reichenberg A, Evans CJ, McGuire P, Lewis G, Jones DK, David AS.

Neuroimage Clin. 2016 Sep 4;12:550-558.

7.

Comparing group-based acceptance and commitment therapy (ACT) with enhanced usual care for adolescents with functional somatic syndromes: a study protocol for a randomised trial.

Kallesøe KH, Schröder A, Wicksell RK, Fink P, Ørnbøl E, Rask CU.

BMJ Open. 2016 Sep 15;6(9):e012743. doi: 10.1136/bmjopen-2016-012743.

8.

Diagnostic validity of the Patient Health Questionnaire-2 (PHQ-2) among Ethiopian adults.

Gelaye B, Wilson I, Berhane HY, Deyessa N, Bahretibeb Y, Wondimagegn D, Shibre Kelkile T, Berhane Y, Fann JR, Williams MA.

Compr Psychiatry. 2016 Oct;70:216-21. doi: 10.1016/j.comppsych.2016.07.011.

PMID:
27567282
9.

Increased DNA and RNA damage by oxidation in patients with bipolar I disorder.

Jacoby AS, Vinberg M, Poulsen HE, Kessing LV, Munkholm K.

Transl Psychiatry. 2016 Aug 9;6(8):e867. doi: 10.1038/tp.2016.141.

10.

Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients.

Nieuwenhuis M, Schnack HG, van Haren NE, Lappin J, Morgan C, Reinders AA, Gutierrez-Tordesillas D, Roiz-Santiañez R, Schaufelberger MS, Rosa PG, Zanetti MV, Busatto GF, Crespo-Facorro B, McGorry PD, Velakoulis D, Pantelis C, Wood SJ, Kahn RS, Mourao-Miranda J, Dazzan P.

Neuroimage. 2017 Jan 15;145(Pt B):246-253. doi: 10.1016/j.neuroimage.2016.07.027.

11.

The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study.

de Witte LD, van Mierlo HC, Litjens M, Klein HC, Bahn S, Osterhaus AD; GROUP Investigators..

NPJ Schizophr. 2015 Nov 4;1:15041. doi: 10.1038/npjschz.2015.41.

12.

The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study.

van Mierlo HC, de Witte L, Derksen RH, Otten HG; GROUP investigators..

NPJ Schizophr. 2015 May 6;1:15013. doi: 10.1038/npjschz.2015.13.

13.

Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study.

de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M.

NPJ Schizophr. 2015 Apr 1;1:15001. doi: 10.1038/npjschz.2015.1.

14.

Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness.

Johnstone M, Maclean A, Heyrman L, Lenaerts AS, Nordin A, Nilsson LG, De Rijk P, Goossens D, Adolfsson R, St Clair DM, Hall J, Lawrie SM, McIntosh AM, Del-Favero J, Blackwood DH, Pickard BS.

Mol Neuropsychiatry. 2015 Oct;1(3):175-190.

15.

Insomnia and hallucinations in the general population: Findings from the 2000 and 2007 British Psychiatric Morbidity Surveys.

Sheaves B, Bebbington PE, Goodwin GM, Harrison PJ, Espie CA, Foster RG, Freeman D.

Psychiatry Res. 2016 Jul 30;241:141-6. doi: 10.1016/j.psychres.2016.03.055.

16.

Awareness of Pre-diabetes or Diabetes and Associated Factors in People With Psychosis.

Foley DL, Mackinnon A, Morgan VA, Watts GF, Castle DJ, Waterreus A, Galletly CA.

Schizophr Bull. 2016 Sep;42(5):1280-9. doi: 10.1093/schbul/sbw027.

PMID:
27150636
17.

Do better executive functions buffer the effect of current parental depression on adolescent depressive symptoms?

Davidovich S, Collishaw S, Thapar AK, Harold G, Thapar A, Rice F.

J Affect Disord. 2016 Jul 15;199:54-64. doi: 10.1016/j.jad.2016.03.049.

18.

Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study.

Simons CJ, Bartels-Velthuis AA, Pijnenborg GH; Genetic Risk and Outcome of Psychosis (GROUP) Investigators..

PLoS One. 2016 Apr 15;11(4):e0151299. doi: 10.1371/journal.pone.0151299.

19.

Environmental Social Stress, Paranoia and Psychosis Liability: A Virtual Reality Study.

Veling W, Pot-Kolder R, Counotte J, van Os J, van der Gaag M.

Schizophr Bull. 2016 Nov;42(6):1363-1371.

PMID:
27038469
20.

Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population.

Molina JL, González Alemán G, Florenzano N, Padilla E, Calvó M, Guerrero G, Kamis D, Stratton L, Toranzo J, Molina Rangeon B, Hernández Cuervo H, Bourdieu M, Sedó M, Strejilevich S, Cloninger CR, Escobar JI, de Erausquin GA.

Schizophr Bull. 2016 Nov;42(6):1486-1495.

PMID:
26994395
Items per page

Supplemental Content

Support Center